Autolus Therapeutics (AUTL) Other Gross PP&E Adjustments (2017 - 2025)
Historic Other Gross PP&E Adjustments for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to -$10.5 million.
- Autolus Therapeutics' Other Gross PP&E Adjustments rose 4038.88% to -$10.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.5 million, marking a year-over-year increase of 4038.88%. This contributed to the annual value of -$18.0 million for FY2024, which is 5373.4% up from last year.
- Per Autolus Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$10.5 million for Q3 2025, which was up 4038.88% from -$11.6 million recorded in Q2 2025.
- Over the past 5 years, Autolus Therapeutics' Other Gross PP&E Adjustments peaked at $10.5 million during Q4 2021, and registered a low of -$54.3 million during Q2 2023.
- For the 5-year period, Autolus Therapeutics' Other Gross PP&E Adjustments averaged around -$14.7 million, with its median value being -$13.2 million (2022).
- As far as peak fluctuations go, Autolus Therapeutics' Other Gross PP&E Adjustments surged by 21729.52% in 2021, and later tumbled by 297545.35% in 2023.
- Quarter analysis of 5 years shows Autolus Therapeutics' Other Gross PP&E Adjustments stood at $10.5 million in 2021, then tumbled by 67.64% to $3.4 million in 2022, then tumbled by 1245.05% to -$39.0 million in 2023, then soared by 53.73% to -$18.0 million in 2024, then skyrocketed by 41.65% to -$10.5 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$10.5 million for Q3 2025, versus -$11.6 million for Q2 2025 and -$12.5 million for Q1 2025.